US equities
|
NVDA
$239.56
▲+2.40%
SPCX
$169.64
▲+6.72%
MU
$1,061.75
▼-1.22%
TSLA
$380.48
▲+2.67%
SNDK
$1,697.98
▼-1.28%
MSFT
$528.52
▲+2.12%
INTC
$116.45
▼-2.41%
META
$743.58
▲+2.13%
NVDA
$239.56
▲+2.40%
SPCX
$169.64
▲+6.72%
MU
$1,061.75
▼-1.22%
TSLA
$380.48
▲+2.67%
SNDK
$1,697.98
▼-1.28%
MSFT
$528.52
▲+2.12%
INTC
$116.45
▼-2.41%
META
$743.58
▲+2.13%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Zomedica Corp. Common Shares
(NY:
ZOM
)
0.0973
UNCHANGED
Last Price
Updated: 8:00 PM EST, Mar 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zomedica Corp. Common Shares
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses
June 13, 2022
ANN ARBOR, MI / ACCESSWIRE / June 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion...
From
Zomedica Corp.
Via
AccessWire
Topics
Law Enforcement
Zomedica to Present at JMP Securities Life Sciences Conference
June 08, 2022
ANN ARBOR, MI / ACCESSWIRE / June 8, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for...
From
Zomedica Corp.
Via
AccessWire
Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary
June 02, 2022
ANN ARBOR, MI / ACCESSWIRE / June 2, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for...
From
Zomedica Corp.
Via
AccessWire
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line
May 19, 2022
ANN ARBOR, MI / ACCESSWIRE / May 19, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion...
From
Zomedica Corp.
Via
AccessWire
Dogs Win, Investors Lose With Zomedica
↗
March 24, 2022
Zomedica still has cash from pushing its Truforma device last year, but the future of ZOM stock is based on PulseNet, bought in October.
Via
InvestorPlace
Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp.
May 18, 2022
NEW YORK, NY / ACCESSWIRE / May 18, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a...
From
Traders News Source
Via
AccessWire
Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans
May 16, 2022
ANN ARBOR, MI / ACCESSWIRE / May 16, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for...
From
Zomedica Corp.
Via
AccessWire
Why Zomedica Shares Are Falling Today
↗
May 11, 2022
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 4.99% at $0.20. The company reported first-quarter earnings results during Tuesday’s after-hours session. Zomedica reported a first-quarter EPS...
Via
Benzinga
Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues
May 10, 2022
ANN ARBOR, MI / ACCESSWIRE / May 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for...
From
Zomedica Corp.
Via
AccessWire
It’s Going to Take a Lot to Get Zomedica Stock Out of the Doghouse
↗
March 09, 2022
ZOM stockholders are likely to grow increasingly frustrated with management's misplaced optimism and the lack of Truforma sales.
Via
InvestorPlace
Zomedica’s Shareholders Should Be Worried About the Outlook of ZOM Stock
↗
February 16, 2022
ZOM stock has been a toxic asset for nearly a year, and Zomedica isn't giving investors much to get enthused about.
Via
InvestorPlace
Earnings Scheduled For May 10, 2022
↗
May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Via
Benzinga
Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship
May 04, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Zomedica Corp.
Via
AccessWire
Stocks That Hit 52-Week Lows On Thursday
↗
April 28, 2022
During Thursday, 849 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
April 27, 2022
Wednesday's session saw 784 companies set new 52-week lows.
Via
Benzinga
Continue to Steer Clear of MULN Stock
↗
April 27, 2022
Small-cap, battleground EV play MULN stock could deliver a blow to bears, but for today investors should simply avoid a poor investment.
Via
InvestorPlace
Zomedica to Present at H.C. Wainwright Global Investment Conference
April 27, 2022
ANN ARBOR, MI / ACCESSWIRE / April 27, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals,...
From
Zomedica Corp.
Via
AccessWire
Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association
April 13, 2022
ANN ARBOR, MI / ACCESSWIRE / April 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion...
From
Zomedica Corp.
Via
AccessWire
Zomedica Announces Launch of eACTH Assay for Truforma(R) Platform
April 04, 2022
ANN ARBOR, MI / ACCESSWIRE / April 4, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion...
From
Zomedica Corp.
Via
AccessWire
Zomedica (NYSE American: ZOM) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
March 08, 2022
Via
Investor Brand Network
Zomedica (NYSE American: ZOM) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
March 08, 2022
Via
CryptoCurrencyWire
Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica?
↗
March 03, 2022
ΖΟM stock is a penny stock that is trying to make a turnaround. A positive catalyst is present in the form of sales growth.
Via
InvestorPlace
Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results
March 01, 2022
ANN ARBOR, MI / ACCESSWIRE / March 1, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion...
From
Zomedica Corp.
Via
AccessWire
Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin
February 25, 2022
ANN ARBOR, MI / ACCESSWIRE / February 25, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion...
From
Zomedica Corp.
Via
AccessWire
Earnings Scheduled For February 25, 2022
↗
February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...
Via
Benzinga
My Top Things To Expect This Week
↗
February 22, 2022
This week will bring earnings that give insight into multiple investment themes and other important events that you should watch out for.
Via
InvestorPlace
26 Stocks Moving in Friday's Pre-Market Session
↗
February 18, 2022
Gainers Energy Vault Holdings, Inc. (NYSE: NRGV) rose 34.2% to $14.90 in pre-market trading after jumping around 14% on Thursday. Energy Vault Holdings recently started...
Via
Benzinga
56 Biggest Movers From Yesterday
↗
February 17, 2022
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead...
Via
Benzinga
Zomedica Appoints Adrian Lock to Lead Sales Organization
February 15, 2022
ANN ARBOR, MI / ACCESSWIRE / February 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion...
From
Zomedica Corp.
Via
AccessWire
Zomedica Announces Management Team Additions
February 09, 2022
ANN ARBOR, MI / ACCESSWIRE / February 9, 2022 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals,...
From
Zomedica Corp.
Via
AccessWire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
